Summit Global Investments’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-37,000
Closed -$890K – 298
2019
Q4
$890K Buy
37,000
+1,000
+3% +$22.8K 0.1% 159
2019
Q3
$760K Buy
36,000
+7,300
+25% +$151K 0.09% 212
2019
Q2
$633K Sell
28,700
-5,600
-16% -$130K 0.08% 251
2019
Q1
$811K Buy
+34,300
New +$801K 0.1% 122

Other funds holding TBI

Summit Global Investments's TBI Position: Q1 2020 in Review

Summit Global Investments sold out of Trueblue (TBI) in Q1 2020, closing a stake of 37,000 shares — an estimated $890K sold.

Summit Global Investments first reported a position in TBI in Q1 2019 and held it in 4 quarters. The position peaked at $890K in Q4 2019. 157 funds tracked by Wall St. Rank hold TBI as of Q1 2020.

  • Summit Global Investments reported no remaining Trueblue position as of Q1 2020 after selling out during the quarter.
  • Summit Global Investments sold 37,000 Trueblue shares in Q1 2020, an estimated $890K.
  • Summit Global Investments first reported a position in Trueblue in Q1 2019 and held it in 4 quarters.
  • Summit Global Investments's Trueblue position peaked at $890K in Q4 2019.
  • 157 funds tracked by Wall St. Rank held Trueblue as of Q1 2020.

Based on Summit Global Investments's 13F filing for Q1 2020, filed 14 May 2020.